📌 Key Takeaways
- Topic: Hollow Glass Microspheres vs Hollow Silica: Lightweight Fillers Compared
- Keywords: silica for printing ink
- Published: 2026-11-20 07:46:37
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Thermal Expansion Coefficient: CTE Values for Quartz vs Fused Silica
- Silica Manufacturers List: Global and Chinese Producers by Product Type
- Lyophilization can be safely used for heat-sensitive drug substances because the drug is formulated at low temperatures and low pressure. Another advantage compared to direct compression is that the poor flowability does not cause problems here, and the pore structure of the nanoparticle is not damaged in the absence of compression. The freeze-drying process can be divided into three main steps: freezing, primary drying, and secondary drying [ 101 ]. The loaded carriers are homogenized with the prepared polymer solution [ 102, 103 ], containing matrix agents (PEG, polyvinyl alcohol (PVA), hydroxyethyl cellulose (HEC), polyvinylpyrrolidone (PVP), alginate, dextran), cryoprotectants (sucrose, or sugar alcohols such as mannitol, sorbitol), surfactants (polysorbates, sorbitan monooleate), super disintegrants (croscarmellose sodium) [ 102 ]. The resulting dispersion is filled into blisters and then lyophilized [ 102, 103 ]. During the process, the desired tablet shape is formed, adapting to the shape of the blister [ 102 ]. They are characterized by rapid disintegration (less than 30 s), low moisture content, and rapid dissolution [ 41, 102, 103 ]. Elmowafy et al. effectively optimized lyophilized tablet formulations using quercetin-loaded MSN carriers [ 41 ]. PVP-K30 was used as a polymeric stabilizer, PEG 6000 as a co-binding polymer, and sucrose as a cryoprotectant. This freeze-dried formulation permits fast disintegration and low friability (less than 1%). Importantly, the saturation solubility and the dissolution rate, and so the oral bioavailability of the poorly water-soluble quercetin boosted particularly, and it can be further improved by sublingual application [ 41 ]. Utilizing the right composition, an orally dispersible tablet can be produced, which is why its sublingual use is advantageous, because the API goes directly into the systemic circulation (bypassing the enteral circulation, so the first pass impact does not apply), hence improving oral bioavailability [ 41, 100 ]. Besides immediate drug release, sustained and even targeted drug release is also available, provided by appropriate formulation, thus increasing the therapeutic possibilities. These days, gastroretentive and mucoadhesive freeze-dried tablets are also available, further broadening the spectrum [ 102, 103 ].
- Silica Powder Price: What Determines Cost and Typical Price Ranges
- Silica as a Desiccant: Moisture Capacity, Types and Uses
- 70. Shirani M.P., Ensafi A.A., Rezaei B., Amirghofran Z. Folic acid and carbon dots-capped mesoporous silica for pH-responsive targeted drug delivery and bioimaging. J. Iran. Chem. Soc. 2023;20:2257-2268. doi: 10.1007/s13738-023-02831-9. [ DOI ] [ Google Scholar ]
- Silica Supplier Thailand: Market Overview and Sourcing Options
- 4. Drug Loading
Is Silica in Cosmetics Safe? Ingredient Safety and Regulatory Status
What is silica (SiO₂)?
silica food additive Even though MSNs can usually be recognized as secure products, their use during therapy may cause side impacts in the body [ 1, 2, 29 ]. Due to their small size and large surface area, they may tend to accumulate in the body, or certain organs (liver, spleen, kidney, lung) and may even be toxic in higher concentrations, which is a clear disadvantage [ 1, 4, 27 ]. The silanol groups (Si-OH) on their surface can interact with the phospholipid layer of the cell membrane, thereby causing cell lysis or, in extreme cases, hemolysis [ 4, 8 ]. In severe cases, the lack of hemocompatibility can also cause issues [ 2 ]. Overall, indications of cytotoxicity, haemotoxicity, and genotoxicity were also found [ 4, 8 ]. That is why the biocompatibility of all comparable preparations must be strictly controlled [ 2, 4, 27 ]. The physicochemical features (particle size, particle morphology, surface chemistry, pore structure, etc.) of nanocarriers also have a major impact on toxicity [ 2, 4, 8, 30 ]. Additionally, further attention must be paid to the biological influences of their decomposition products, because they may also cause unwanted side influences [ 1 ]. The breakdown of silica nanoparticles in the body can take up to a few days. The opening hydration is followed by hydrolysis, and, in the end, they are excreted in the urine in the form of silicic acid [ 1 ]. Nevertheless, the literature is contradictory in this regard [ 31 ]. Some experiments show no considerable cytotoxic effect [ 18, 31 ], while other experiments say otherwise [ 23, 32 ]. For example, an in vitro study was performed with multiple concentrations, surfaces, and particle sizes (60 nm, 100 nm, 300 nm) of MSNs, with an exposure time of 72 h [ 18 ]. This study shown no significant cytotoxic influence in any of the cell lines tested (human cervical (HeLA), epithelial lung (A549), and glioblastoma (U251)) [ 18 ]. Ismail et al. investigated the cytotoxic effect of silica nanoparticles in vivo in mouse models [ 33 ]. Amorphous silica nanoparticles were administered to the animals orally, at a dose of 150 mg/kg/day, for 3 months. Based on these mouse models, no toxic effects were detected under sub-chronic treatment of the nanoparticles [ 31 ]. In another study, particle size (15 nm, 60 nm, 200 nm) dependent impact was observed on cellular viability in all four cell lines tested (THP-1 derived macrophages, A549 epithelial cells, HaCaT keratinocytes, and NRK-52E kidney cells) [ 23 ]. Smaller particles caused notable toxicity on each cell line, after the exposure time of 24 h, in contrast to the larger particles, which demonstrated no cytotoxic impact [ 23 ]. A comparable outcome has been published to verify the toxic characteristic of mesoporous silica. In this in vitro study, the researchers investigated the effect of MSNs with an average size of 7 nm on cell viability at three different concentrations. After 72 h of exposure, only the highest concentration (62.5 µg/mL) caused a substantial decrease in cell viability of human lung fibroblast cells. This toxicity occurred in a time- and dose-dependent manner [ 32 ]. In an in vivo mouse model, MacCuaig et al. presented coating-dependent impacts after repeated intravenous administration of MSNs. Chitosan-coated MSNs induced minor organ changes and were the most biocompatible. Uncoated and especially PEG-coated MSNs (especially 2K PEG) moderately augmented pre-existing vascular or organ lesions, implying that PEGylation has the potential to augment chronic risks, while chitosan enables safer long-term use [ 34 ]. An in vitro study of Barguilla et al. exposed epithelial lung cells to bare, PEG-functionalized, or galacto-oligosaccharide-functionalized MSNs for eight weeks. There was no reported long-term DNA damage, but malignant-like alterations like anchorage-independent growth, boosted migration/invasion, and secretome-facilitated tumor promotion were triggered by PEG- and GAL-functionalized MSNs. Naked MSNs did not cause such alterations and were determined to be safer [ 35 ]. Coating, on the whole, exerts a significant impact on the safety of MSNs. Uncoated MSNs are relatively innocuous; the most biocompatible coatings were achieved with chitosan, but PEG and carbohydrate functionalization can be dangerous in the long run, from vascular toxicity in vivo to tumor-promoting activity in vitro [ 34, 35 ].
What is the difference between fumed silica and precipitated silica?
silica supplier Mexico Wet granulation is the most frequently used technique to process MSNs, because of the many possibilities inherent in it [ 106 ]. Conventional wet granulation is well-suited for the granulation of silica nanocarriers, but several things should be considered during implementation. There are two possible sequences: first, the drug loading, followed by the granulation of the loaded carriers [ 104 ], or the opposite way, the granulation of the empty carriers, then loading the drug into the prepared granules. In the first case, during the planning and implementation of the process, special attention must be paid to the critical process parameters to steer clear of premature drug release [ 104 ]. In general, it can be noted that as little moisture as possible should be used during granulation, consequently decreasing the risk of premature drug release. Still, simultaneously, moisture adequate to produce the desired agglomeration must be made sure [ 104 ]. The risk of premature drug release depends to a certain extent on the chemical structure of the API and the carrier. Szewczyk and Prokopowicz developed doxycycline-loaded MSN pellets with prolonged release kinetics [ 40 ]. First, the drug was loaded into the pores, and then pellets were produced from the loaded mesoporous material with other excipients by wet extrusion and spheronization. For comparison, traditional doxycycline pellets were also prepared. This study demonstrated the importance of utilizing mesoporous carriers for the delayed or sustained release of water-soluble drugs. Pelletization was a successful method to reduce the initial burst release of doxycycline; twice the release time was observed compared to traditional pellets [ 40 ]. Szewczyk et al. developed another DDS loaded with an antibiotic compound (cefazolin) for the treatment of osteomyelitis [ 66 ]. The amine-functionalized MSN was successfully loaded with the drug, and because of the powerful interactions between the negatively charged cefazolin and the positively charged surface of the carrier, a prolonged release of 5 days was observed, which made sure a longer antibacterial influence than with classic pellets. This was proven by the microbiological activity assays of the pellets against S. aureus culture [ 66 ]. These results are promising in antibiotic or anticancer therapy, where therapeutic concentration is needed for a longer period [ 40, 66 ]. A comparable outcome was presented in another publication about metformin-containing MSN pellets with prolonged release kinetics [ 85 ]. After drug loading, pellets were formed with the mixture of the preloaded carriers and chitosan solution, and then the pellets were coated with five layers of chitosan. Since the stomach is not considered the best possible absorption surface for metformin, it is advisable to delay the release until conditions in the intestines are ideal for maximum bioavailability. Chitosan plays an important role in this formulation; it slows down and delays the metformin release and offers delayed and prolonged release kinetics, thereby preventing speedy blood level peaks after application [ 85 ]. On the contrary, Wang et al. published a post on MSN pellets filled with poorly water-soluble carbamazepine, and they observed better oral bioavailability compared to commercially available tablets based on in vivo analysis performed on dogs [ 86 ]. In vitro dissolution studies confirmed a raised dissolution rate compared to crystalline carbamazepine due to the amorphous state of the drug within the pores. This immediate-release pellet formulation allows for a reduction in the drug dose, sustaining the same clinical influence [ 86 ].
What drives silica raw material prices?
surface treated silica 7.1.2. Freeze-Dried Tablets
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.